Life Healthcare (LHC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Life Healthcare (LHC) has a cash flow conversion efficiency ratio of 0.083x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ZAC993.00 Million ≈ $527.73K USD) by net assets (ZAC11.94 Billion ≈ $6.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Life Healthcare for the company's overall valuation and market capitalisation.
Life Healthcare - Cash Flow Conversion Efficiency Trend (2009–2025)
This chart illustrates how Life Healthcare's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Life Healthcare Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Life Healthcare ranked by their cash flow conversion efficiency. Explore Life Healthcare cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hyosung TNC Corp
KO:298020
|
0.065x |
|
ATEX Resources Inc.
V:ATX
|
-0.185x |
|
Accel Entertainment Inc
NYSE:ACEL
|
0.155x |
|
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
|
N/A |
|
Ningbo Dechang Electrical Machinery Made Co Ltd
SHG:605555
|
-0.019x |
|
SAF Holland SA
XETRA:SFQ
|
0.082x |
|
Telsys
TA:TLSY
|
0.107x |
|
Mingyue Optical Lens Co.Ltd.
SHE:301101
|
N/A |
Annual Cash Flow Conversion Efficiency for Life Healthcare (2009–2025)
The table below shows the annual cash flow conversion efficiency of Life Healthcare from 2009 to 2025. View current stock price of Life Healthcare for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | ZAC12.14 Billion ≈ $6.45 Million |
ZAC4.04 Billion ≈ $2.15 Million |
0.333x | +20.87% |
| 2024-09-30 | ZAC13.51 Billion ≈ $7.18 Million |
ZAC3.72 Billion ≈ $1.98 Million |
0.275x | +25.59% |
| 2023-09-30 | ZAC21.29 Billion ≈ $11.31 Million |
ZAC4.67 Billion ≈ $2.48 Million |
0.219x | +2.94% |
| 2022-09-30 | ZAC19.86 Billion ≈ $10.55 Million |
ZAC4.23 Billion ≈ $2.25 Million |
0.213x | -20.55% |
| 2021-09-30 | ZAC19.17 Billion ≈ $10.19 Million |
ZAC5.14 Billion ≈ $2.73 Million |
0.268x | +21.32% |
| 2020-09-30 | ZAC18.28 Billion ≈ $9.71 Million |
ZAC4.04 Billion ≈ $2.15 Million |
0.221x | -16.93% |
| 2019-09-30 | ZAC17.49 Billion ≈ $9.30 Million |
ZAC4.66 Billion ≈ $2.47 Million |
0.266x | -2.88% |
| 2018-09-30 | ZAC16.20 Billion ≈ $8.61 Million |
ZAC4.44 Billion ≈ $2.36 Million |
0.274x | +14.44% |
| 2017-09-30 | ZAC15.55 Billion ≈ $8.26 Million |
ZAC3.72 Billion ≈ $1.98 Million |
0.239x | -46.71% |
| 2016-09-30 | ZAC6.80 Billion ≈ $3.61 Million |
ZAC3.06 Billion ≈ $1.62 Million |
0.449x | -1.40% |
| 2015-09-30 | ZAC6.45 Billion ≈ $3.43 Million |
ZAC2.94 Billion ≈ $1.56 Million |
0.456x | +6.04% |
| 2014-09-30 | ZAC5.90 Billion ≈ $3.14 Million |
ZAC2.54 Billion ≈ $1.35 Million |
0.430x | -7.66% |
| 2013-09-30 | ZAC5.61 Billion ≈ $2.98 Million |
ZAC2.61 Billion ≈ $1.39 Million |
0.465x | -1.02% |
| 2012-09-30 | ZAC4.88 Billion ≈ $2.59 Million |
ZAC2.29 Billion ≈ $1.22 Million |
0.470x | +5.96% |
| 2011-09-30 | ZAC4.38 Billion ≈ $2.33 Million |
ZAC1.95 Billion ≈ $1.03 Million |
0.444x | -15.07% |
| 2010-09-30 | ZAC3.52 Billion ≈ $1.87 Million |
ZAC1.84 Billion ≈ $976.28K |
0.523x | +9.22% |
| 2009-09-30 | ZAC2.93 Billion ≈ $1.56 Million |
ZAC1.40 Billion ≈ $745.12K |
0.478x | -- |
About Life Healthcare
Life Healthcare Group Holdings Limited, an investment holding company, operates as a private healthcare company in Southern Africa. It operates through Southern Africa " Hospitals Services, Southern Africa - Complementary Services, Southern Africa - Healthcare Services, and International segments. The company operates acute hospitals; and Life Nkanyisa care centres that provide long-term chronic … Read more